The Stem Cell Podcast

Ep. 213: “Hematopoietic Stem Cell Biology” Featuring Dr. Kelly McNagny

Mar 8, 2022

01:13:10

Creator website

Highlights

AI Chapters

Episode notes

Cell Signalling in Mammalian Cells

04:15

Is This a Stem Cell Story Per Se?

04:22

Solid Tumors Are a Tough Not to Crack

04:46

Introduction

3min

Cell Signalling in Mammalian Cells

4min

Is This a Stem Cell Story Per Se?

4min

Directry Programming of Cell Types Into Cardimicites

5min

Is Direct Programming a Good Idea?

6min

Chronic Kidney Disease

2min

Organoids in Vitro - Identifying a Drug Candidate

6min

Organoid Story - Modeling Clemidia Co-Infection in Cervical Stem Cells

4min

Vaccination

4min

10.

Is It Going to Take to Produce Bonefied Hematipotic Stem Cells From Pluripotent Stems?

2min

11.

Is Stem Cells in a Dishes a Thick Nut to Crack?

3min

12.

Is There Really a Need for Hemata Poetic Stem Cells?

3min

13.

How Does a Bacterial Metabolite Affect Your Immune System?

2min

14.

The Poto Clixs Molecule

5min

15.

Is There a Strategy to Kill Tumor Cells?

4min

16.

Is There a Therapeutic Approach to Malignancy?

3min

17.

Solid Tumors Are a Tough Not to Crack

5min

18.

Ye, I'm a Chemical Engineer, and I Grew Up in Rural Virginian Than Rural Massachusetts

5min

19.

Doctor McCann, What's the Best Piece of Advice That You've Ever Been Given?

5min

Dr. Kelly McNagny is a Professor of Medical Genetics and Biomedical Engineering at the University of British Columbia. His research program is focused on hematopoietic stem cell biology, specifically in understanding the signaling networks that regulate stem cell differentiation and how these cells interact with their microenvironment. He talks about how hematopoietic stem cell differentiation is related to chronic inflammatory disorders, targeting glycosylation in solid tumors, and his international career path.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.